Lilly Targets Sanofi With Diabetes Drug’s Weight Loss

Lilly Targets Sanofi With Diabetes Drug’s Weight Loss

Victor J. Blue/Bloomberg

If similar results are found in a larger study, Eli Lilly & Co.’s experimental insulin may be the first to help patients lose weight.